Loading clinical trials...
Loading clinical trials...
A Prospective, Multicenter, Exploratory Study of Venetoclax, Homoharringtonine, and Azacitidine Combined With G-CSF in Elderly or Unfit Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions
Interventions
Intervention for Venetoclax
Intervention for Homoharringtonine
+2 more
Locations
1
China
Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University
Hangzhou, Zhejiang, China
Start Date
March 31, 2026
Primary Completion Date
March 31, 2028
Completion Date
March 31, 2029
Last Updated
April 2, 2026
NCT07500441
NCT05768932
NCT05756777
NCT07451912
NCT06660368
NCT05143996
Lead Sponsor
First People's Hospital of Hangzhou
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions